Syndax Pharmaceuticals Inc.
SNDX | NASDAQ
$18.21
+$0.14 (+0.77%)
Sep 22, 2026, 11:35 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 252M | 217.17M | 172.35M | 111.55M | 78.18M | 43.72M | 23.68M | 16M | 3.5M | n/a | n/a | n/a | n/a | n/a | n/a | 126.58M | 138.95M | 139.33M | 139.71M | 13.51M | 1.52M | 1.52M |
Cost of Revenue | 6.37M | 4.44M | 2.69M | 4.26M | 2.16M | 885K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 121K | 121K | 121K | 121K | 1K | 1K | 1K |
Gross Profit | 245.64M | 212.73M | 169.66M | 107.29M | 76.02M | 42.84M | 23.68M | 16M | 3.5M | n/a | n/a | n/a | n/a | n/a | n/a | 126.46M | 138.83M | 139.21M | 139.59M | 13.51M | 1.52M | 1.52M |
Operating Income | -194.17M | -223.53M | -273.08M | -306.9M | -339.05M | -343.92M | -339.67M | -321.21M | -287.99M | -263.45M | -229.95M | -194.08M | -172.87M | -160.91M | -151.76M | -13.97M | 1.14M | 16.53M | 26.22M | -89.39M | -89.21M | -83.49M |
Interest Income | 22.17M | 24.38M | 28M | 25.51M | 25.68M | 26.02M | 26.09M | 24.53M | 24.44M | 23.34M | 21.16M | 18.6M | 15.04M | 10.72M | 5.87M | 2.97M | 1.28M | 506K | 402K | 417K | 511K | 628K |
Pretax Income | -220.77M | -243.25M | -285.42M | -311.58M | -334.99M | -331.2M | -318.76M | -297.06M | -264.08M | -240.63M | -209.36M | -176.08M | -160.34M | -153.3M | -149.34M | -13.95M | 818K | 15.48M | 24.93M | -91.7M | -91.49M | -85.65M |
Net Income | -220.77M | -243.25M | -285.42M | -311.58M | -334.99M | -331.2M | -318.76M | -297.06M | -264.08M | -240.63M | -209.36M | -176.08M | -160.34M | -153.3M | -149.34M | -13.95M | 818K | 15.48M | 24.93M | -91.7M | -91.49M | -85.65M |
Selling & General & Admin | 173.97M | 176.24M | 179.68M | 167.44M | 153.63M | 138.89M | 120.88M | 105.97M | 92.13M | 77.98M | 66.92M | 54.34M | 45.31M | 38.38M | 33.26M | 29.99M | 28.55M | 26.41M | 25.24M | 23.03M | 22.06M | 22.26M |
Research & Development | 261.8M | 255.99M | 258.78M | 245.67M | 260.36M | 246.79M | 241.65M | 231.24M | 199.36M | 185.47M | 163.03M | 139.75M | 127.56M | 122.53M | 118.5M | 110.56M | 109.26M | 96.4M | 88.25M | 79.87M | 68.67M | 62.74M |
Other Expenses | 4.03M | 4.03M | 4.28M | 1.07M | 1.07M | 1.07M | 826K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50K | -107K | -107K | -107K | -96K |
Operating Expenses | 439.81M | 436.26M | 442.74M | 414.19M | 415.07M | 386.75M | 363.35M | 337.21M | 291.49M | 263.45M | 229.95M | 194.08M | 172.87M | 160.91M | 151.76M | 140.55M | 137.82M | 122.81M | 113.49M | 102.9M | 90.73M | 85M |
Interest Expense | 85.51M | 80.69M | 76.89M | 29M | 20.74M | 12.93M | 4.93M | 186K | 233K | 223K | 208K | 188K | 1.87M | 2.53M | 3.14M | 3.09M | 2M | 1.93M | 1.91M | 2.54M | 2.53M | 2.53M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 446.18M | 440.7M | 445.44M | 418.45M | 417.23M | 387.64M | 363.35M | 337.21M | 291.49M | 263.45M | 229.95M | 194.08M | 172.87M | 160.91M | 151.76M | 140.55M | 137.82M | 122.81M | 113.49M | 102.9M | 90.73M | 85M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 88.99M | 86.62M | 86.62M | 86.62M | 86.34M | 85.62M | 85.79M | 85.43M | 85.27M | 85.21M | 72.52M | 69.86M | 69.64M | 69.44M | 63.19M | 60.67M | 60.16M | 58.98M | 51.79M | 51.96M | 51.6M | 51.5M |
Shares Outstanding (Diluted) | 88.99M | 86.62M | 86.62M | 86.62M | 86.34M | 85.62M | 85.79M | 85.43M | 85.27M | 85.21M | 72.52M | 69.86M | 69.64M | 69.44M | 63.19M | 60.67M | 60.16M | 58.98M | 53.18M | 51.96M | 51.6M | 51.5M |
EPS (Basic) | -2.52 | -2.80 | -3.30 | -3.62 | -3.90 | -3.87 | -3.73 | -3.63 | -3.38 | -3.22 | -2.96 | -2.58 | -2.43 | -2.41 | -2.45 | -0.02 | 0.16 | 0.34 | 0.43 | -1.82 | -1.88 | -1.86 |
EPS (Diluted) | -2.52 | -2.80 | -3.30 | -3.62 | -3.90 | -3.87 | -3.73 | -3.63 | -3.38 | -3.22 | -2.96 | -2.58 | -2.43 | -2.41 | -2.45 | -0.02 | 0.16 | 0.34 | 0.43 | -1.82 | -1.88 | -1.86 |
EBITDA | -135.25M | -162.5M | -215.43M | -289.48M | -321.16M | -325.24M | -313.82M | -296.87M | -263.84M | -240.4M | -209.14M | -175.88M | -158.46M | -150.74M | -146.17M | -10.7M | 2.96M | 17.56M | 26.99M | -89.19M | -88.99M | -83.13M |
EBIT | -135.26M | -162.56M | -224.63M | -298.68M | -330.35M | -334.38M | -313.83M | -296.88M | -263.85M | -240.41M | -209.15M | -175.89M | -158.47M | -150.77M | -146.2M | -10.85M | 2.81M | 17.41M | 26.83M | -89.15M | -88.97M | -83.11M |
Depreciation & Amortization | 10K | 65K | 9.2M | 9.2M | 9.2M | 9.14M | 8K | 11K | 12K | 12K | 12K | 12K | 17K | 25K | 33K | 151K | 151K | 245K | 351K | 251K | 266K | 183K |
Add to Watchlist
Select watchlists to add or remove SNDX